Moerman Mieke B J
Institute of Phoniatrics, University Medical Centre Utrecht, the Netherlands.
Curr Opin Otolaryngol Head Neck Surg. 2006 Dec;14(6):431-6. doi: 10.1097/MOO.0b013e328010b85b.
Botulinum injection is a widespread technique for treating oropharyngeal dysphagia although there are no standards or guidelines. Based on the literature review we try to make some recommendations.
In the last 12 months molecular and pharmacological research has reported the working mechanism of the various botulinum toxin types which tries to explain former clinical observations such as variable response rate and therefore dosage, and toxin type specific resistance. Recent dose-ranging studies or comparisons of different toxin preparations or types rarely focus on oropharyngeal dysphagia.
Injection of botulinum toxin A should be considered in cases of relative hypertonicity of the cricopharyngeal muscle and has an onset around day 7 and an offset of at least 4 months. The technique is simple and the complication rate is extremely low (7/100). There are some conditions for success: injection in the horizontal part of the cricopharyngeal muscle, and a high enough start dose. Botulinum injection may be preferred over surgical myotomy because of the low risk, low cost and effectiveness of the procedure. Only in cases of BoNT/A resistance should other toxin types be used.
尽管没有标准或指南,但肉毒杆菌注射是治疗口咽吞咽困难的一种广泛应用的技术。基于文献综述,我们试图提出一些建议。
在过去12个月里,分子和药理学研究报告了各种肉毒杆菌毒素类型的作用机制,试图解释以前的临床观察结果,如可变的反应率以及因此而产生的剂量,还有毒素类型特异性耐药性。最近的剂量范围研究或不同毒素制剂或类型的比较很少关注口咽吞咽困难。
对于环咽肌相对张力亢进的病例,应考虑注射A型肉毒杆菌毒素,其起效时间约为第7天,作用持续至少4个月。该技术简单,并发症发生率极低(7/100)。成功有一些条件:在环咽肌水平部分注射,起始剂量足够高。由于该手术风险低、成本低且有效,肉毒杆菌注射可能比手术肌切开术更可取。仅在对A型肉毒毒素耐药的情况下才应使用其他毒素类型。